AfterNext HealthTech Acquisition Corp Units
AFTR.U
AFTR.U was delisted on the 15th of August, 2023.
10 hedge funds and large institutions have $12.8M invested in AfterNext HealthTech Acquisition Corp Units in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
4% more capital invested
Capital invested by funds: $12.3M → $12.8M (+$506K)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$59K |
| 2 |
GCL
Glazer Capital LLC
New York
|
+$2.03K |
| 3 |
Jane Street
New York
|
+$761 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$8.25K |
AFTR.U Hedge Fund Activity: Q1 2023 in Review
10 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in AfterNext HealthTech Acquisition Corp Units (AFTR.U) for Q1 2023, worth a combined $12.8M — up 4.1% from $12.3M a quarter earlier.
Fund positioning in AFTR.U was balanced in Q1 2023: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Clear Street, adding an estimated $59K. The largest seller was UBS Group, cutting an estimated $8.25K.
- 10 institutional investors held AfterNext HealthTech Acquisition Corp Units (AFTR.U) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $12.8M of AfterNext HealthTech Acquisition Corp Units stock for Q1 2023, up 4.1% quarter-over-quarter.
- 0 funds opened new AfterNext HealthTech Acquisition Corp Units positions in Q1 2023 and 0 closed out.
- The largest AfterNext HealthTech Acquisition Corp Units buyer in Q1 2023 was Clear Street, an estimated $59K added.
- The largest AfterNext HealthTech Acquisition Corp Units seller in Q1 2023 was UBS Group, an estimated $8.25K sold.
Based on aggregated 13F filings for Q1 2023.